Abstract
Purpose
Although influenza vaccine contains some residual egg protein (ovalbumin), recent studies have been reported that the influenza vaccine is even safe for patients with egg allergy. The object of this study was to assess the safety of influenza vaccination and estimate the risk factors of allergic reactions to influenza vaccination in children with egg allergy.
Methods
The medical records of 108 children were reviewed retrospectively, those were diagnosed as egg allergy at Department of Pediatrics in Severance Children's Hospital between January 2006 and December 2011. All of them were vaccinated with very low ovalbumin concentration (≤0.12 µg/mL). Patients were vaccinated in graded doses by the international guideline. Subjects without allergic reactions to influenza vaccine among egg allergy patients were recruited as control subjects.
Results
Only 12 subjects of patients had adverse reactions to influenza vaccination. There were no significant relationships between adverse reactions to influenza vaccine and their own history of other allergy, history of breast feeding or graded vaccination. The egg allergy symptoms or egg-specific IgE levels were not associated with adverse reactions to influenza vaccination.
Conclusion
These results show that patients with egg allergy may have adverse reactions with influenza vaccine, but severe adverse reactions are rare as general population. Therefore, the patients with egg allergy can be safe vaccinated with influenza vaccine, regardless of severity of allergic reaction after egg ingestion or methods of vaccination.
References
1. World Health Organization Writing Group. Bell D, Nicoll A, Fukuda K, Horby P, Monto A, et al. Non-pharmaceutical interventions for pandemic influenza, international measures. Emerg Infect Dis. 2006; 12:81–87.


2. Zeiger RS. Current issues with influenza vaccination in egg allergy. J Allergy Clin Immunol. 2002; 110:834–840.


3. Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010; 59(RR-8):1–62.
4. Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis Child. 2000; 83:488–491.


5. Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012; 130:25–43.


6. Roh EJ, Chung EH, Kim JK. Quantitative analysis of egg protein by ELISA in distributed influenza vaccine in Korea. Pediatr Allergy Respir Dis. 2009; 19:345–353.
7. Savage JH, Matsui EC, Skripak JM, Wood RA. The natural history of egg allergy. J Allergy Clin Immunol. 2007; 120:1413–1417.


8. Caubet JC, Wang J. Current understanding of egg allergy. Pediatr Clin North Am. 2011; 58:427–443.


9. Shin WJ, Kim SY, Ahn YM. Follow-up study of children with egg allergy: comorbidity of allergic diseases and factors affecting prognosis. Pediatr Allergy Respir Dis. 2004; 14:87–96.
10. Koplin JJ, Dharmage SC, Ponsonby AL, Tang ML, Lowe AJ, Gurrin LC, et al. Environmental and demographic risk factors for egg allergy in a population-based study of infants. Allergy. 2012; 67:1415–1422.


11. Upton JE, Hummel DB, Kasprzak A, Atkinson AR. No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients. Allergy Asthma Clin Immunol. 2012; 8:2.


12. James JM, Zeiger RS, Lester MR, Fasano MB, Gern JE, Mansfield LE, et al. Safe administration of influenza vaccine to patients with egg allergy. J Pediatr. 1998; 133:624–628.


13. Webb L, Petersen M, Boden S, LaBelle V, Bird JA, Howell D, et al. Single-dose influenza vaccination of patients with egg allergy in a multicenter study. J Allergy Clin Immunol. 2011; 128:218–219.


14. Erlewyn-Lajeunesse M, Lucas JS, Warner JO. Influenza immunization in egg allergy: an update for the 2011-2012 season. Clin Exp Allergy. 2011; 41:1367–1370.


16. Berger WE. Allergic rhinitis in children: diagnosis and management strategies. Paediatr Drugs. 2004; 6:233–250.
17. Ly NP, Gold DR, Weiss ST, Celedon JC. Recurrent wheeze in early childhood and asthma among children at risk for atopy. Pediatrics. 2006; 117:e1132–e1138.


18. Castro-Rodríguez JA, Holberg CJ, Wright AL, Martinez FD. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000; 162(4 Pt 1):1403–1406.


19. Greenhawt MJ, Chernin AS, Howe L, Li JT, Sanders G. The safety of the H1N1 influenza A vaccine in egg allergic individuals. Ann Allergy Asthma Immunol. 2010; 105:387–393.


20. Hui CP, Macdonald NE. Use of influenza vaccines in children with an egg allergy. Paediatr Child Health. 2011; 16:491–492.


21. Eigenmann PA. Egg allergy; immunological and clinical aspects. Pediatr Allergy Respir Dis. 2004; 14:111–118.
22. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006; 117:391–397.

